This week we had Eyes On the acquisition of Forma Therapeutics by Novo Nordisk - a typically reticent player in the M&A arena.

This week PharmaTell had Eyes On: Heartburn – the kind caused by the upcoming Zantac litigation & resulting market jitters.

This week we had Eyes On Amazon & One Medical – as did many of you, I am sure. We saw the news and, of course, had a variety of thoughts...

We are excited to announce PharmaTech Outlook selected us as one of the Top 10 Pharma Marketing Services Companies in Europe – 2022!

The PharmaTell Team has had Eyes On — The Pharma CI Europe Conference, US FDA Regulatory Updates. Plus 2H22 Clinical Data Readouts.

As with most of you I'm sure - this week the PharmaTell Team had Eyes on ASCO + positive data for postpartum depression patients.